Class II recall: SUN PHARMA /TARO: Lidocaine Ointment USP, 5%, Speermint Flavor, 50 g Jar, Rx only, Mfd. by: Taro P
Sun Pharma/Taro has issued a Class II recall for Lidocaine Ointment USP, 5%, Spearmint Flavor, 50 g Jar (NDC 51672-3008-5). The recall was initiated due to failed content uniformity specifications, with the product found out of specification for assay during analysis at the 24-month long-term stability testing station (25°C, 60% RH).
Most relevant for: Clinicians and pharmacies who prescribe or dispense this specific lot of topical lidocaine 5% ointment.
Read the original at FDA Drug Enforcement ReportsSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More family medicine updates
- Long-Acting Injectable HIV Therapy Noninferior for Adherence ChallengesOct 15, 2026
- 8-week sofosbuvir-velpatasvir regimen non-inferior to 12 weeks for HCVSep 30, 2026
- Lean MASLD shows milder histology but similar mortality outcomesSep 30, 2026
- Oral GLP-1 orforglipron shows cardiovascular non-inferiority to insulin glargineSep 30, 2026
- Retatrutide produces substantial weight loss in phase 3 diabetes trialSep 29, 2026